The PACE trial in chronic fatigue syndrome

Article


Stouten, Bart, Goudsmit, Ellen M and Riley, Neil 2011. The PACE trial in chronic fatigue syndrome. Lancet. 377 (9780), pp. 1832-1833.
AuthorsStouten, Bart, Goudsmit, Ellen M and Riley, Neil
Abstract

The findings of the PACE trial seem impressive, but the discrepancy between the definitions of improvement in the protocol and paper requires an explanation. In the paper “clinically useful differences” were defined as 0·5 SD changes in fatigue or physical functioning compared with baseline. However, the criteria for improvement published in the trial protocol were much more demanding. Use of a cut-off score of 75 on the short-form 36 physical functioning subscale, as originally proposed, would halve the number of “recovered” patients. Moreover, consulting the normative data for the scale reveals that the mean score of 59 after both cognitive behaviour therapy and graded exercise improved a chronic fatigue syndrome patient’s physical functioning to the level of someone 40 years older than
himself. Is this a case of “outcome reporting bias”?

Keywordschronic fatigue syndrome; myalgic encephalomyelitis
JournalLancet
Journal citation377 (9780), pp. 1832-1833
Year2011
Accepted author manuscript
License
CC BY-ND
Web address (URL)http://hdl.handle.net/10552/1573
Publication dates
Print17 May 2011
Publication process dates
Deposited01 May 2012
Additional information

Citation:
Stouten, B., Goudsmit, E. and Riley, N. (2011) 'The PACE trial in chronic fatigue syndrome. The Lancet, 377(9780), pp. 1832-1833, doi: 10.1016/S0140-6736(11)60685-5..

Permalink -

https://repository.uel.ac.uk/item/860w2

  • 4
    total views
  • 46
    total downloads
  • 1
    views this month
  • 5
    downloads this month